Logo image of AVTX.AS

AVANTIUM (AVTX.AS) Stock Fundamental Analysis

Europe - AMS:AVTX - NL0015002IE0 - Common Stock

10.19 EUR
+1.21 (+13.49%)
Last: 9/12/2025, 4:27:57 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AVTX. AVTX was compared to 32 industry peers in the Professional Services industry. AVTX has a bad profitability rating. Also its financial health evaluation is rather negative. AVTX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AVTX has reported negative net income.
AVTX had a negative operating cash flow in the past year.
In the past 5 years AVTX always reported negative net income.
AVTX had a negative operating cash flow in each of the past 5 years.
AVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFAVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

AVTX has a Return On Assets of -9.31%. This is amonst the worse of the industry: AVTX underperforms 87.50% of its industry peers.
With a Return On Equity value of -28.03%, AVTX is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.31%
ROE -28.03%
ROIC N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
AVTX.AS Yearly ROA, ROE, ROICAVTX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

With a decent Gross Margin value of 81.08%, AVTX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
AVTX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AVTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
AVTX.AS Yearly Profit, Operating, Gross MarginsAVTX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVTX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AVTX has been increased compared to 5 years ago.
AVTX has a worse debt/assets ratio than last year.
AVTX.AS Yearly Shares OutstandingAVTX.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AVTX.AS Yearly Total Debt VS Total AssetsAVTX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

AVTX has an Altman-Z score of -1.89. This is a bad value and indicates that AVTX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.89, AVTX is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.30 indicates that AVTX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.30, AVTX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -1.89
ROIC/WACCN/A
WACC6.97%
AVTX.AS Yearly LT Debt VS Equity VS FCFAVTX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

AVTX has a Current Ratio of 0.25. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
AVTX has a Current ratio of 0.25. This is amonst the worse of the industry: AVTX underperforms 93.75% of its industry peers.
AVTX has a Quick Ratio of 0.25. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
AVTX has a worse Quick ratio (0.24) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.24
AVTX.AS Yearly Current Assets VS Current LiabilitesAVTX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.68% over the past year.
The Revenue has been growing slightly by 6.78% in the past year.
Measured over the past years, AVTX shows a quite strong growth in Revenue. The Revenue has been growing by 8.76% on average per year.
EPS 1Y (TTM)35.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.23%
Revenue 1Y (TTM)6.78%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-2.9%

3.2 Future

AVTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.52% yearly.
Based on estimates for the next years, AVTX will show a very strong growth in Revenue. The Revenue will grow by 54.51% on average per year.
EPS Next Y24.87%
EPS Next 2Y24.61%
EPS Next 3Y23.84%
EPS Next 5Y11.52%
Revenue Next Year56.1%
Revenue Next 2Y67.42%
Revenue Next 3Y50.4%
Revenue Next 5Y54.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVTX.AS Yearly Revenue VS EstimatesAVTX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AVTX.AS Yearly EPS VS EstimatesAVTX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVTX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVTX.AS Price Earnings VS Forward Price EarningsAVTX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVTX.AS Per share dataAVTX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as AVTX's earnings are expected to grow with 23.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.61%
EPS Next 3Y23.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTIUM

AMS:AVTX (9/12/2025, 4:27:57 PM)

10.19

+1.21 (+13.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-13 2025-08-13
Earnings (Next)N/A N/A
Inst Owners5.62%
Inst Owner ChangeN/A
Ins Owners4.91%
Ins Owner ChangeN/A
Market Cap89.67M
Analysts75
Price Target36.16 (254.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12%
PT rev (3m)741.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)17.59%
EPS NY rev (3m)-760.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.5%
Revenue NY rev (3m)-10.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-3.59
EYN/A
EPS(NY)-4.06
Fwd EYN/A
FCF(TTM)-10.75
FCFYN/A
OCF(TTM)-4.09
OCFYN/A
SpS2.39
BVpS10.89
TBVpS10.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -28.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.08%
FCFM N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
F-Score2
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1126.95%
Cap/Sales 278.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.24
Altman-Z -1.89
F-Score2
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)919.16%
Cap/Depr(5y)570.66%
Cap/Sales(3y)308.29%
Cap/Sales(5y)199.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.23%
EPS Next Y24.87%
EPS Next 2Y24.61%
EPS Next 3Y23.84%
EPS Next 5Y11.52%
Revenue 1Y (TTM)6.78%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-2.9%
Revenue Next Year56.1%
Revenue Next 2Y67.42%
Revenue Next 3Y50.4%
Revenue Next 5Y54.51%
EBIT growth 1Y-10.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.85%
EBIT Next 3Y27.71%
EBIT Next 5Y18.14%
FCF growth 1Y11.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.37%
OCF growth 3YN/A
OCF growth 5YN/A